2,000 Medicines to Become Cheaper: Nadda

Union Health Minister J.P. Nadda has said nearly 2,000 medicines will be made available at rates up to 90 per cent less than the maximum retail price (MRP) under the Amrut Scheme. “Two thousand medicines will be made available at 60 to 90 percent less rates than the MRP,” said the Minister on Saturday while addressing the foundation stone laying ceremony here of the proposed Super Specialty Block of Jabalpur Medical College. He said such retail stores would also be opened in Madhya Pradesh. Nadda said the central government would…

Read More

Insulin, hepatitis B shots may get cheaper

Scientists at Institute of Microbial Technology, Chandigarh, have for the first time in India developed indigenous technology to produce protein-based medicines like insulin, streptokinase (clot buster) and the hepatitis B vaccine. They expect this to cut the cost of these medicines by 3-4 times. India is largely dependent on imported and patented technology (expression vector) for production of insulin, streptokinase and hepatitis B etc. The importance of IMTECH’s work can be gauged from the fact that India is No.2 in the world after China in diabetes and hepatitis B patients:…

Read More

Apple Unveils Smaller, Cheaper iPhone SE for Emerging Markets

Apple Inc on Monday unveiled a smaller, cheaper iPhone aimed at new buyers, especially in emerging markets and China, as the technology company looks to reverse a decline in worldwide sales of its most important product. The new device, called the iPhone SE, has a 4-inch (10-cm) screen and starts at $399. It represents Apple’s second bid for the crowded mid-tier market after an unsuccessful foray three years ago. Orders start on Thursday, and the phone will be available next week. The $399 (roughly Rs. 26,300) starting price is well…

Read More